Expanding access to cancer clinical trials in North Texas
Official title: UT Southwestern NCI National Clinical Trials Network (NCTN) LAPS - Funded Extension Supplement YR6
Funded at Ut Southwestern Medical Center · NIH-11252722 · Data updated 2026-11-12
This study is all about helping more people, especially those from diverse backgrounds in the Dallas/Ft. Worth area, join cancer clinical trials so they can access the latest treatments and improve their health outcomes.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Ut Southwestern Medical Center NIH-funded |
| Lab location | 1 site (Dallas, United States) |
| Project start | January 2, 2025 |
| Project end | February 28, 2026 |
| Funding year | 2025 |
| Award (this year) | $440,784 |
| NIH project number | 3UG1CA233302-06S1 |
| Project ID | NIH-11252722 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for participation are adults aged 21 and older, particularly those from diverse backgrounds or underrepresented populations in cancer research.
✕Less likely to help
Patients who are not diagnosed with cancer or those who do not meet the eligibility criteria for specific clinical trials may not benefit from this research.
What this research studies
This research focuses on enhancing participation in cancer clinical trials through the National Clinical Trials Network at UT Southwestern Medical Center. The project aims to enroll a diverse patient population, particularly from the Dallas/Ft. Worth area, to ensure that underrepresented groups have access to cutting-edge cancer treatments. By leveraging the center's leadership roles in clinical trials and its comprehensive cancer care facilities, the research seeks to improve patient outcomes and advance cancer treatment options. The methodology includes patient recruitment, trial management, and collaboration with various cancer research committees.
Why it matters
Potential benefit: If successful, this research could significantly improve access to innovative cancer treatments for patients in North Texas.
How similar studies have gone: Previous research has demonstrated success in increasing clinical trial enrollment through targeted outreach and community engagement strategies.
Where this research is happening
-
Ut Southwestern Medical Center
Dallas, United States Active
Researchers
- Principal investigator: Gerber, David Eric — Ut Southwestern Medical Center
- Study coordinator: Gerber, David Eric
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.